NuStar GP Holdings, (NSH) Is At $15.95 Formed Wedge; Cambrex Has 1.58 Sentiment

January 3, 2018 - By Richard Conner

Cambrex Corporation, a life sciences company, provides various services and products for the development and commercialization of new and generic therapeutics worldwide. The company has market cap of $1.69 billion. The companyÂ’s products comprise active pharmaceutical ingredients and pharmaceutical intermediates that are used in the production of prescription and over-the-counter drug products, as well as other fine chemicals. It has a 17.26 P/E ratio. It serves generic drug companies; and companies that discover and commercialize small molecule human therapeutics.

NuStar GP Holdings, LLC (NSH) formed wedge down with $15.31 target or 4.00% below today’s $15.95 share price. NuStar GP Holdings, LLC (NSH) has $685.08M valuation. The stock increased 1.59% or $0.25 during the last trading session, reaching $15.95. About 333,590 shares traded or 26.07% up from the average. NuStar GP Holdings, LLC (NYSE:NSH) has risen 4.83% since January 3, 2017 and is uptrending. It has underperformed by 11.87% the S&P500.

Analysts await NuStar GP Holdings, LLC (NYSE:NSH) to report earnings on January, 30. They expect $0.29 earnings per share, up 107.14% or $0.15 from last year’s $0.14 per share. NSH’s profit will be $12.46M for 13.75 P/E if the $0.29 EPS becomes a reality. After $0.26 actual earnings per share reported by NuStar GP Holdings, LLC for the previous quarter, Wall Street now forecasts 11.54% EPS growth.

Among 9 analysts covering Nustar GP Holdings (NYSE:NSH), 2 have Buy rating, 0 Sell and 7 Hold. Therefore 22% are positive. Nustar GP Holdings had 18 analyst reports since September 11, 2015 according to SRatingsIntel. Barclays Capital initiated the shares of NSH in report on Wednesday, November 25 with “Equal-Weight” rating. The stock of NuStar GP Holdings, LLC (NYSE:NSH) earned “Buy” rating by Citigroup on Tuesday, October 10. The stock of NuStar GP Holdings, LLC (NYSE:NSH) has “Neutral” rating given on Friday, February 3 by Citigroup. Barclays Capital maintained NuStar GP Holdings, LLC (NYSE:NSH) rating on Wednesday, November 8. Barclays Capital has “Equal-Weight” rating and $21 target. The firm earned “Buy” rating on Tuesday, December 5 by Citigroup. As per Friday, September 30, the company rating was initiated by Mizuho. The firm has “Hold” rating given on Monday, July 17 by Wells Fargo. The rating was downgraded by Credit Suisse on Thursday, November 3 to “Underperform”. Wells Fargo upgraded NuStar GP Holdings, LLC (NYSE:NSH) on Friday, April 21 to “Outperform” rating. Macquarie Research initiated NuStar GP Holdings, LLC (NYSE:NSH) on Friday, April 21 with “Neutral” rating.

Investors sentiment decreased to 0.79 in Q3 2017. Its down 0.04, from 0.83 in 2017Q2. It worsened, as 9 investors sold NuStar GP Holdings, LLC shares while 20 reduced holdings. 7 funds opened positions while 16 raised stakes. 22.58 million shares or 0.24% less from 22.64 million shares in 2017Q2 were reported. The Ontario – Canada-based Brookfield Asset Mgmt has invested 0.01% in NuStar GP Holdings, LLC (NYSE:NSH). Commonwealth Of Pennsylvania Pub School Empls Retrmt holds 0.15% or 476,160 shares in its portfolio. Sei holds 0% of its portfolio in NuStar GP Holdings, LLC (NYSE:NSH) for 1,032 shares. Glob X Management Co Llc owns 1,195 shares or 0% of their US portfolio. Hsbc Pcl, United Kingdom-based fund reported 119,563 shares. Cushing Asset Management Lp accumulated 35,800 shares. Barclays Public Ltd reported 14,726 shares or 0% of all its holdings. Brown Advisory owns 10,000 shares. Bnp Paribas Arbitrage Sa owns 4,675 shares for 0% of their portfolio. Gp One Trading Lp reported 1,009 shares. Peak Asset Mngmt Ltd Liability Co accumulated 10,800 shares. Glenmede Na, a Pennsylvania-based fund reported 41,143 shares. Credit Suisse Ag has 0.01% invested in NuStar GP Holdings, LLC (NYSE:NSH) for 280,639 shares. Alps Advsr has invested 0% in NuStar GP Holdings, LLC (NYSE:NSH). Texas Yale Capital invested in 0.24% or 125,225 shares.

Since August 23, 2017, it had 3 insider purchases, and 0 sales for $2.12 million activity. 20,279 NuStar GP Holdings, LLC (NYSE:NSH) shares with value of $422,858 were bought by GREEHEY WILLIAM E.

Ranger Investment Management L.P. holds 2.91% of its portfolio in Cambrex Corporation for 704,978 shares. Zpr Investment Management owns 34,205 shares or 2.85% of their US portfolio. Moreover, Jw Asset Management Llc has 2.04% invested in the company for 50,519 shares. The New York-based American Capital Management Inc has invested 1.94% in the stock. Neumeier Poma Investment Counsel Llc, a California-based fund reported 335,675 shares.

The stock increased 7.40% or $3.55 during the last trading session, reaching $51.55. About 531,417 shares traded or 27.33% up from the average. Cambrex Corporation (CBM) has risen 11.15% since January 3, 2017 and is uptrending. It has underperformed by 5.55% the S&P500.

Analysts await Cambrex Corporation (NYSE:CBM) to report earnings on February, 2. They expect $1.11 earnings per share, down 5.93% or $0.07 from last year’s $1.18 per share. CBM’s profit will be $36.39 million for 11.61 P/E if the $1.11 EPS becomes a reality. After $0.55 actual earnings per share reported by Cambrex Corporation for the previous quarter, Wall Street now forecasts 101.82% EPS growth.